• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于RNA测序的食管鳞状细胞癌微小RNA表达特征:抗肿瘤性微小RNA-143-5p和微小RNA-143-3p调控的致癌靶点

RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation.

作者信息

Wada Masumi, Goto Yusuke, Tanaka Takako, Okada Reona, Moriya Shogo, Idichi Tetsuya, Noda Masahiro, Sasaki Ken, Kita Yoshiaki, Kurahara Hiroshi, Maemura Kosei, Natsugoe Shoji, Seki Naohiko

机构信息

Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical Sciences, Kagoshima University, Kagoshima, Japan.

Department of Functional Genomics, Graduate School of Medicine, Chiba University, Chiba, Japan.

出版信息

J Hum Genet. 2020 Nov;65(11):1019-1034. doi: 10.1038/s10038-020-0795-x. Epub 2020 Jul 4.

DOI:10.1038/s10038-020-0795-x
PMID:32623445
Abstract

Aberrantly expressed microRNAs (miRNAs) disrupt intracellular RNA networks and contribute to malignant transformation of cancer cells. Utilizing the latest RNA sequencing technology, we newly created the miRNA expression signature of esophageal squamous cell carcinoma (ESCC). A total of 47 miRNAs were downregulated in ESCC tissues, and these miRNAs were candidates for antitumor miRNAs in ESCC cells. Analysis of the signature revealed that several passenger strands of miRNAs were significantly downregulated in ESCC, e.g., miR-28-3p, miR-30a-3p, miR-30c-3p, miR-133a-3p, miR-139-3p, miR-143-5p, and miR-145-3p. Recent studies indicate that some passenger strands of miRNAs closely involved in cancer pathogenesis. In this study, we focused on both strands of pre-miR-143, and investigated their antitumor roles and target oncogenes in ESCC. Ectopic expression of miR-143-5p and miR-143-3p significantly attenuated malignant phenotypes (e.g., proliferation, migration, and invasive abilities) in ESCC cell lines. We revealed that six genes (HN1, HMGA2, NETO2, STMN1, TCF3, and MET) were putative targets of miR-143-5p regulation, and one gene (KRT80) was a putative target of miR-143-3p regulation in ESCC cells. Our ESCC miRNA signature and analysis strategy provided important insights into the molecular pathogenesis of ESCC.

摘要

异常表达的微小RNA(miRNA)破坏细胞内RNA网络,并促进癌细胞的恶性转化。利用最新的RNA测序技术,我们新创建了食管鳞状细胞癌(ESCC)的miRNA表达特征。共有47种miRNA在ESCC组织中下调,这些miRNA是ESCC细胞中抗肿瘤miRNA的候选者。对该特征的分析表明,几种miRNA的过客链在ESCC中显著下调,例如miR-28-3p、miR-30a-3p、miR-30c-3p、miR-133a-3p、miR-139-3p、miR-143-5p和miR-145-3p。最近的研究表明,一些miRNA的过客链与癌症发病机制密切相关。在本研究中,我们聚焦于pre-miR-143的两条链,并研究了它们在ESCC中的抗肿瘤作用和靶癌基因。miR-143-5p和miR-143-3p的异位表达显著减弱了ESCC细胞系中的恶性表型(如增殖、迁移和侵袭能力)。我们发现六个基因(HN1、HMGA2、NETO2、STMN1、TCF3和MET)是ESCC细胞中miR-143-5p调控的假定靶标,一个基因(KRT80)是miR-143-3p调控的假定靶标。我们的ESCC miRNA特征和分析策略为ESCC的分子发病机制提供了重要见解。

相似文献

1
RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation.基于RNA测序的食管鳞状细胞癌微小RNA表达特征:抗肿瘤性微小RNA-143-5p和微小RNA-143-3p调控的致癌靶点
J Hum Genet. 2020 Nov;65(11):1019-1034. doi: 10.1038/s10038-020-0795-x. Epub 2020 Jul 4.
2
RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.基于 RNA 测序的乳腺癌 microRNA 表达特征:抑癌 miR-101-5p 调控分子发病机制。
Mol Oncol. 2020 Feb;14(2):426-446. doi: 10.1002/1878-0261.12602. Epub 2019 Dec 29.
3
Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.基于深度测序的头颈部鳞状细胞癌微小RNA表达特征:前体微小RNA-150双链作为抗肿瘤微小RNA
Oncotarget. 2017 May 2;8(18):30288-30304. doi: 10.18632/oncotarget.16327.
4
Regulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma.双链 miR-150 前体调控 SPOCK1 抑制食管鳞癌细胞迁移和侵袭。
J Hum Genet. 2017 Nov;62(11):935-944. doi: 10.1038/jhg.2017.69. Epub 2017 Jun 29.
5
Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.基于 The Cancer Genome Atlas (TCGA) 和生物信息学的食管鳞癌新型生物标志物 microRNAs 的鉴定:一项研究。
Chin Med J (Engl). 2019 Sep 20;132(18):2213-2222. doi: 10.1097/CM9.0000000000000427.
6
Impact of Oncogenic Targets by Tumor-Suppressive and Regulation in Head and Neck Squamous Cell Carcinoma.抑癌基因对头颈部鳞状细胞癌中致癌靶点的调控作用。
Int J Mol Sci. 2021 Sep 14;22(18):9947. doi: 10.3390/ijms22189947.
7
Molecular pathogenesis of esophageal squamous cell carcinoma: Identification of the antitumor effects of miR‑145‑3p on gene regulation.食管鳞状细胞癌的分子发病机制:miR-145-3p 对基因调控的抗肿瘤作用鉴定。
Int J Oncol. 2019 Feb;54(2):673-688. doi: 10.3892/ijo.2018.4657. Epub 2018 Dec 6.
8
Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis.miR-30a-3p 调控致癌靶点在胰腺导管腺癌发病机制中的作用。
Int J Mol Sci. 2020 Sep 4;21(18):6459. doi: 10.3390/ijms21186459.
9
Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.miR-223 双链的两条互补链(miR-223-5p 和 miR-223-3p)抑制癌细胞侵袭性:靶基因参与膀胱癌的发病机制。
J Hum Genet. 2018 May;63(5):657-668. doi: 10.1038/s10038-018-0437-8. Epub 2018 Mar 14.
10
Down-regulation of miR-30a-3p/5p promotes esophageal squamous cell carcinoma cell proliferation by activating the Wnt signaling pathway.下调 miR-30a-3p/5p 通过激活 Wnt 信号通路促进食管鳞癌细胞增殖。
World J Gastroenterol. 2017 Dec 7;23(45):7965-7977. doi: 10.3748/wjg.v23.i45.7965.

引用本文的文献

1
miR-195-5p Suppresses KRT80 Expression Inducing Cell Cycle Arrest in Colon Cancer.miR-195-5p通过抑制KRT80表达诱导结肠癌细胞周期停滞。
Cancers (Basel). 2025 Jun 28;17(13):2183. doi: 10.3390/cancers17132183.
2
Targeting Drp1 inhibits ESCC progression via the ROS-PGC1-α-Nrf1/2 pathway.靶向动力相关蛋白1(Drp1)通过活性氧(ROS)-过氧化物酶体增殖物激活受体γ共激活因子1α(PGC1-α)-核因子E2相关因子1/2(Nrf1/2)途径抑制食管鳞状细胞癌(ESCC)进展。
J Transl Med. 2025 Jun 17;23(1):674. doi: 10.1186/s12967-025-06697-8.
3
Biomarkers of lymph node metastasis in esophageal cancer.

本文引用的文献

1
Pan-cancer analysis reveals cooperativity of both strands of microRNA that regulate tumorigenesis and patient survival.泛癌症分析揭示了调控肿瘤发生和患者生存的 miRNA 双链的协同作用。
Nat Commun. 2020 Feb 20;11(1):968. doi: 10.1038/s41467-020-14713-2.
2
MiR-145: a potential biomarker of cancer migration and invasion.微小RNA-145:癌症迁移和侵袭的潜在生物标志物。
Am J Transl Res. 2019 Nov 15;11(11):6739-6753. eCollection 2019.
3
RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
食管癌淋巴结转移的生物标志物。
Front Immunol. 2024 Sep 27;15:1457612. doi: 10.3389/fimmu.2024.1457612. eCollection 2024.
4
Tuberculosis to lung cancer: application of tuberculosis signatures in identification of lung adenocarcinoma subtypes and marker screening.从结核病到肺癌:结核病特征在肺腺癌亚型鉴定和标志物筛选中的应用
J Cancer. 2024 Aug 13;15(16):5329-5350. doi: 10.7150/jca.97898. eCollection 2024.
5
The BET PROTAC inhibitor GNE-987 displays anti-tumor effects by targeting super-enhancers regulated gene in osteosarcoma.BET PROTAC 抑制剂 GNE-987 通过靶向骨肉瘤中超增强子调控的基因发挥抗肿瘤作用。
BMC Cancer. 2024 Aug 1;24(1):928. doi: 10.1186/s12885-024-12691-y.
6
MicroRNA-143 overexpression enhances the chemosensitivity of A172 glioblastoma cells to carmustine.微小RNA-143过表达增强A172胶质母细胞瘤细胞对卡莫司汀的化疗敏感性。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):533-542. doi: 10.1007/s00210-024-03287-1. Epub 2024 Jul 15.
7
The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers.长链非编码RNA和微小RNA在胰腺癌中的作用:聚焦于癌症的发生发展及其作为潜在生物标志物的作用
Front Oncol. 2024 Mar 15;14:1355064. doi: 10.3389/fonc.2024.1355064. eCollection 2024.
8
miR-877-5p as a Potential Link between Triple-Negative Breast Cancer Development and Metabolic Syndrome.miR-877-5p 作为三阴性乳腺癌发展与代谢综合征之间的潜在联系。
Int J Mol Sci. 2023 Nov 25;24(23):16758. doi: 10.3390/ijms242316758.
9
Investigation of the effects of phthalates on thyroid models with RNA-Seq and ATAC-Seq.采用 RNA-Seq 和 ATAC-Seq 技术研究邻苯二甲酸酯对甲状腺模型的影响。
Front Endocrinol (Lausanne). 2023 Sep 22;14:1200211. doi: 10.3389/fendo.2023.1200211. eCollection 2023.
10
, Regulated by Multiple microRNAs, Facilitates Cancer Cell Aggressiveness in Pancreatic Ductal Adenocarcinoma.多种 microRNAs 调控,促进胰腺导管腺癌癌细胞侵袭转移。
Genes (Basel). 2023 Apr 27;14(5):995. doi: 10.3390/genes14050995.
基于 RNA 测序的乳腺癌 microRNA 表达特征:抑癌 miR-101-5p 调控分子发病机制。
Mol Oncol. 2020 Feb;14(2):426-446. doi: 10.1002/1878-0261.12602. Epub 2019 Dec 29.
4
lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.长链非编码 RNA CCAT1 通过 miR-143/PLK1/BUBR1 轴促进食管癌的增殖和耐药。
Mol Carcinog. 2019 Dec;58(12):2207-2217. doi: 10.1002/mc.23109. Epub 2019 Sep 22.
5
Recent progress in multidisciplinary treatment for patients with esophageal cancer.食管癌多学科综合治疗的新进展。
Surg Today. 2020 Jan;50(1):12-20. doi: 10.1007/s00595-019-01878-7. Epub 2019 Sep 18.
6
Oncological role of HMGA2 (Review).HMGA2 的肿瘤学作用(综述)。
Int J Oncol. 2019 Oct;55(4):775-788. doi: 10.3892/ijo.2019.4856. Epub 2019 Aug 13.
7
Long noncoding RNA HAGLR acts as a microRNA-143-5p sponge to regulate epithelial-mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3.长链非编码 RNA HAGLR 通过调节 LAMP3 作为 microRNA-143-5p 的海绵体调控食管癌上皮-间充质转化和转移潜能。
FASEB J. 2019 Sep;33(9):10490-10504. doi: 10.1096/fj.201802543RR. Epub 2019 Jul 15.
8
Biological and clinical relevance of metastasis-associated long noncoding RNAs in esophageal squamous cell carcinoma: A systematic review.转移相关长非编码 RNA 在食管鳞癌中的生物学和临床意义:系统综述。
J Cell Physiol. 2020 Feb;235(2):848-868. doi: 10.1002/jcp.29083. Epub 2019 Jul 16.
9
Long non-coding RNA LINC01207 silencing suppresses AGR2 expression to facilitate autophagy and apoptosis of pancreatic cancer cells by sponging miR-143-5p.长链非编码 RNA LINC01207 通过海绵吸附 miR-143-5p 抑制 AGR2 表达,促进胰腺癌细胞自噬和凋亡。
Mol Cell Endocrinol. 2019 Aug 1;493:110424. doi: 10.1016/j.mce.2019.04.004. Epub 2019 Apr 13.
10
Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy.晚期食管鳞状细胞癌的系统治疗:化疗、分子靶向治疗和免疫治疗。
Jpn J Clin Oncol. 2019 May 1;49(5):412-420. doi: 10.1093/jjco/hyz034.